Clinical Trial Detail

NCT ID NCT03267888
Title Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

multiple myeloma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.